Novo CEO pressed by Senate to chop price ranges of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the company would contemplate new talks with insurers about the checklist selling prices of Wegovy and copyright if they pledge to keep the medicines on their own formularies. Financial commitment https://josuevmiyu.blogoxo.com/30799895/healthcare-news-things-to-know-before-you-buy